A randomized trial challenges many years of warning about caffeine, discovering that modest each day espresso consumption didn’t worsen atrial fibrillation and was related to fewer clinically detected recurrences.
The DECAF trial: coffee, caffeine, and atrial fibrillation. Picture Credit score: vagabondatheart / Shutterstock
In a current article revealed within the journal Cardiovascular Research, authors Christopher Wong and Gregory Marcus mentioned findings from the DECAF randomized clinical trial, which evaluated whether or not each day consumption of caffeinated espresso, in contrast with abstinence from espresso and caffeine, impacts the chance of recurrent atrial fibrillation (AF) or atrial flutter in sufferers with AF.
Background
Historically, espresso and caffeine have been regarded as doable triggers of AF or elements that might worsen arrhythmias, thus prompting docs to advise their sufferers to remove or restrict caffeinated drinks from their weight-reduction plan. However, most observational research haven’t recognized an elevated danger of creating AF amongst espresso drinkers, and a few research have implied that those that drink extra espresso may also have a decrease danger of creating AF, though residual or unmeasured confounding stays doable.
Randomized proof has additionally been reassuring: Individualized Research of Triggers of Paroxysmal Atrial Fibrillation (I-STOP-AFib) discovered no vital enhance in AF with caffeine publicity, whereas Espresso and Actual-time Atrial and Ventricular Ectopy (CRAVE) discovered no vital enhance in untimely atrial contractions with caffeinated espresso.
As a result of no randomized trial had instantly examined espresso consumption in folks with AF, the Does Eliminating Espresso Keep away from Fibrillation (DECAF) trial was designed to find out whether or not caffeinated espresso impacts AF recurrence.
Research overview
The DECAF trial was an investigator-initiated, worldwide, multicenter, randomized medical trial evaluating whether or not caffeinated espresso consumption impacts recurrence of AF or atrial flutter. The research included 200 sufferers with persistent AF, or atrial flutter with a historical past of AF, who have been scheduled for electrical cardioversion.
Eligible sufferers needed to have consumed a minimum of one cup of caffeinated espresso per day in some unspecified time in the future within the final 5 years. Eligibility additionally included individuals who have been now not consuming caffeinated espresso due to private beliefs or doctor recommendation relating to AF.
Following profitable cardioversion, individuals have been randomized 1:1 to both devour a minimum of one cup of caffeinated espresso each day or abstain from all espresso, together with decaffeinated espresso, and caffeinated merchandise. Observe-up lasted for six months or till an incidence of AF or flutter. Median espresso consumption within the espresso group was 7 cups per week, whereas median consumption within the abstinence group was 0 cups per week.
Key findings
In accordance with the first evaluation primarily based on the intention-to-treat precept, individuals allotted to caffeinated espresso had a 39% decrease hazard of recurrent clinically recognized AF or atrial flutter in contrast with these assigned to abstain from espresso and caffeine through the research interval. The hazard ratio was equal to 0.61 (95% confidence interval, 0.42-0.89; P=0.01). No variations in hostile occasions have been discovered between teams.
The authors emphasize that the findings problem the longstanding perception that caffeinated espresso can precipitate or worsen AF. At minimal, the outcomes recommend that modest caffeinated espresso consumption, roughly one cup each day, is unlikely to worsen AF in most people, and whether or not espresso supplies a direct protecting profit requires additional investigation.
Attainable mechanisms
The organic mechanisms underlying the findings stay unsure as a result of espresso incorporates quite a few biologically lively compounds. Caffeine blocks A1 and A2a adenosine receptors, doubtlessly counteracting adenosine-mediated results that may facilitate AF induction. Some observational knowledge additionally recommend that caffeinated, however not decaffeinated, espresso is related to a decrease danger of AF.
Different hypothesized doubtlessly helpful mechanisms embody the antivagal, anti-inflammatory, antioxidant, and antifibrotic properties of espresso constituents. Espresso may additionally affect cardiometabolic elements related to AF, together with blood stress, bodily exercise, adiposity, and coronary heart failure. Nevertheless, the article additionally acknowledges doubtlessly pro-arrhythmic mechanisms, together with caffeine-related calcium launch, elevated blood stress, and behavioral elements similar to added sugar or smoking.
Limitations and implications
The trial had limitations, together with the problem of conducting randomized trials involving on a regular basis way of life behaviors. The deliberate follow-up was initially 12 months however was diminished to six months as a result of extended caffeine abstinence was anticipated to hinder recruitment.
Practically 2,000 sufferers needed to be screened to enroll 200 individuals. The authors subsequently emphasize the significance of further randomized trials to enrich observational and mechanistic proof and to offer larger confidence in adjustments to medical observe.
Conclusion
The DECAF trial challenges the longstanding observe of routinely proscribing caffeinated espresso in folks with atrial fibrillation. Amongst sufferers with AF or flutter present process cardioversion, consuming a minimum of one cup of caffeinated espresso each day was related to a 39% decrease hazard of clinically detected recurrent AF or flutter over six months in contrast with abstaining from espresso and caffeine, with no variations in hostile occasions.
The findings recommend that modest consumption of caffeinated espresso is unlikely to precipitate or worsen AF in most sufferers. Nevertheless, additional analysis is required to grasp the mechanisms and decide whether or not caffeinated espresso supplies a real protecting profit.
